Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
Share Facebook Twitter LinkedIn Pinterest Email Q3 net sales fell 9.7% year-over-year to $498.2 million as selling price increases and the benefits from currency translation were more than offset by lower […]
